Last updated on August 2020

Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer


Brief description of study

A phase II study to evaluate antitumor activity of oral cMET inhibitor INC280 in adult patients with EGFR wild-type, advanced non-small cell lung cancer (NSCLC) as measured by overall response rate (ORR). The study will also evaluate safety and pharmacokinetics of INC280.

Clinical Study Identifier: NCT02414139

Find a site near you

Start Over

Pacific Shores Medical Group SC

Long Beach, CA United States
  Connect »

VA Comprehensive Cancer Center

West Haven, CT United States
  Connect »

Andrew & Patel Associates,

Camp Hill, PA United States
  Connect »

Oncology Consultants

Houston, TX United States
  Connect »

GHS Cancer Intitute

Greenville, SC United States
  Connect »

Henry Ford Hospital SC

Detroit, MI United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Karmanos Cancer Institute

Detroit, MI United States
  Connect »

Decatur Memorial Hospital

Decatur, IL United States
  Connect »

Minneapolis VA Medical Center

Minneaplois, MI United States
  Connect »

St. Luke's Cancer Institute SC-2

Kansas City, MO United States
  Connect »

Novartis Investigative Site

Sao Jose do Rio Preto, Brazil
  Connect »

Novartis Investigative Site

Marseille cedex 20, France
  Connect »

Novartis Investigative Site

Bundang Gu, Korea, Republic of
  Connect »

Novartis Investigative Site

Seoul, Korea, Republic of
  Connect »

Novartis Investigative Site

Gyeonggi do, Korea, Republic of
  Connect »

Novartis Investigative Site

Moscow, Russian Federation
  Connect »

Novartis Investigative Site

Saint Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

St Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

St.-Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Tambov, Russian Federation
  Connect »

Novartis Investigative Site

Las Palmas De Gran Canarias, Spain
  Connect »

Novartis Investigative Site

Birmingham, United Kingdom
  Connect »

Andrew and Patel Associates

Camp Hill, PA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.